Induction androgen deprivation therapy before radical prostatectomy for prostate cancer -initial results

British Journal of Urology

Volumn 77, Issue 3, 1996, Pages 423-428

  Abbas, F ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen deprivation; Cancer; Prostate; Prostatectomy; Surgical margins

Indexed keywords

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; FLUTAMIDE; FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0029985554     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.85118.x     Document Type: Article

References (28)

1. Wingo PA. Tong T, Bolden S. Cancer statistics. CA Cancer J Clin 1995: 45: 8-30
2. Mettlin C, Jones CW. Murphy GP. Trends in prostate cancer care in the United States. 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer l Clin 1993: 43: 81-91
3. Babian RJ, Mettlin C. Krane R et al. The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography: findings of the American Cancer Society National Prostate Cancer Detection Project. Cancer 1992; 69: 1195-200
4. Catalona WJ. Smith US. Ratliff TL. Dodds KM et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Eng Med 1991: 324: 1156-61
5. Catalona WJ, Scott WW. Carcinoma of the prostate. In Walsh PC. Gittes RF. Perlmutter AD et al. eds. Campbell's Urology, 5 edn. Vol 2. Philadelphia: W.B. Saunders Co. 1986: 1477
6. Walsh PC. Jewett HJ. Radical surgery for prostate cancer. Cancer 1980; 45: 1906-11
7. Devonec M, Frendler JP, Monsallier M et al. The significance of the prostatic hypoechoic area: results in 226 ultrasonographically guided prostatic biopsies. J Ural 1990: 143: 316-9
8. Salo JO. Kivisaari L. Rannikko S et al. Computerized tomography and transrectal ultrasonography in the assessment of local extension of prostate cancer before radical retropubic prostatectomy. J Urol 1987; 137: 435-8
9. Poon PY. McCallum RW. Henkelman MM et al Magnetic resonance imaging of the prostate. Radiology 1985: 154: 143-9
10. Mukamel E. Hannah J, Barbaric Z et al. The value of CT und MRI in staging prostatic carcinoma: comparison with the clinical and histological staging. J Urol 1986; 136: 1231-3
11. Richie JP. Management of patients with positive surgical margins following radical prostatectomy. Urol Clin N Ain 1994; 21: 717-23
12. Kozlowski JM. Grayhack JT. Carcinoma of the prostate. In Gillenwater JY. Grayhack JT, Howards SS, Ducke JW eds. Adult and Pédiatrie Urology. 2 edn. Vol. 2. Mosby. St Louis: Year Book, 1991: 1296-9
13. 3 Partin AW, Yoo J, Carter HB et al. The use of prosi.aticspecific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993: 150: 110-4
14. Van Den Ouden D, Bentvelsen FM, Boeve ER et al. Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. Br J Urol 1993; 72: 439-44
15. Givens PR. Cole BS. Richardson G et al. Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 1986: 135: 65-8
16. Schellhammer PF. Radical prostatectomy: patterns of local failure and survival in 67 patients. Urology 1988: 31:191-7
17. Morton RA, Steiner MS, Walsh PC. Cancer control following anatomical radical prostatectomy: an interim report. J Urol 1991; 145: 1197-1200
18. Ackerman DA. Barry JM, Wickhund RA et al. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node métastases at radical prostatectomy. J Urol 1993; 150: 1845-50
19. Paulson DF, Moul JW. Walter PJ. Radical prostateclomy for clinical stage T1-2NOMO prostatic adenocarcinoma: long term results. J Urol 1990: 144: 1180-4
20. Steinberg GD, Walsh PC. Radical prostatectomy. Expanding role in the management of patients with adenocarcinoma of the prostate. Probl Urol 1990; 4: 408-19
21. Bass RB Jr. Barrett DM. Radical retropubic prostatectomy after transurethral prostatic resection. J Urol 1980; 124: 495-7
22. Catalona WJ, Kelly DR. Indications for total prostatectomy. AU A Update Series 1984; 3: Lesson 2
23. 3 Fair WR. Aprikian AG. Cohen D. Sogani P. Reuter V Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer. Clin Invest Med 1993: 16: 516-22
24. Takayama TK, Lange PH. Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol Clin N Am 1994; 21: 687-700
25. Paulson DF. Moul JW. Robertson JE et al. Post-operative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through capsule. J Urol 1990; 143: 1178-82
26. Huggins C, Hodges CV. Studies on prostate cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-7
27. Scott WW, Boyd HL. Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience. J Ural 1961: 101: 86-92
28. Labrie F, Dupont A, Cusan L et al. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and Lupron: the first controlled and randomized trial. Clin Invest Med 1993: 16: 499-509